New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae
Open Access
- 12 August 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (8) , e0135110
Abstract
5-Flucytosine is currently used as an antifungal drug in combination therapy, but fungal pathogens are rapidly able to develop resistance against this drug, compromising its therapeutic action. The understanding of the underlying resistance mechanisms is crucial to deal with this problem. In this work, the S. cerevisiae deletion mutant collection was screened for increased resistance to flucytosine. Through this chemogenomics analysis, 183 genes were found to confer resistance to this antifungal agent. Consistent with its known effect in DNA, RNA and protein synthesis, the most significant Gene Ontology terms over-represented in the list of 5-flucytosine resistance determinants are related to DNA repair, RNA and protein metabolism. Additional functional classes include carbohydrate and nitrogen—particularly arginine—metabolism, lipid metabolism and cell wall remodeling. Based on the results obtained for S. cerevisiae as a model system, further studies were conducted in the pathogenic yeast Candida glabrata. Arginine supplementation was found to relieve the inhibitory effect exerted by 5-flucytosine in C. glabrata. Lyticase susceptibility was found to increase within the first 30min of 5-flucytosine exposure, suggesting this antifungal drug to act as a cell wall damaging agent. Upon exponential growth resumption in the presence of 5-flucytosine, the cell wall exhibited higher resistance to lyticase, suggesting that cell wall remodeling occurs in response to 5-flucytosine. Additionally, the aquaglyceroporin encoding genes CgFPS1 and CgFPS2, from C. glabrata, were identified as determinants of 5-flucytosine resistance. CgFPS1 and CgFPS2 were found to mediate 5-flucytosine resistance, by decreasing 5-flucytosine accumulation in C. glabrata cells.Keywords
This publication has 36 references indexed in Scilit:
- Mutational Analysis of Flucytosine Resistance in Candida glabrataAntimicrobial Agents and Chemotherapy, 2010
- Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentososRevista Iberoamericana de Micologia, 2008
- Pathogenicity and drug resistance in Candida albicans and other yeast speciesActa Microbiologica Et Immunologica Hungarica, 2007
- Molecular Mechanism of Flucytosine Resistance in Candida lusitaniae : Contribution of the FCY2 , FCY1 , and FUR1 Genes to 5-Fluorouracil and Fluconazole Cross-ResistanceAntimicrobial Agents and Chemotherapy, 2007
- Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicansAntimicrobial Agents and Chemotherapy, 2004
- Antifungal drug resistance of pathogenic fungiThe Lancet, 2002
- Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequencesThe Lancet Infectious Diseases, 2002
- Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactionsJournal of Antimicrobial Chemotherapy, 2000
- Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial ResistanceClinical Microbiology Reviews, 1999
- Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicansClinical Microbiology Reviews, 1999